Inactive/Delisted stock

ZimVie Stock (NASDAQ:ZIMV)


Chart

Previous Close

$18.99

52W Range

$8.15 - $19.01

50D Avg

$18.91

200D Avg

$13.49

Market Cap

$535.63M

Avg Vol (3M)

$723.84K

Beta

2.06

Div Yield

-

ZIMV Company Profile


ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,770

IPO Date

Feb 16, 2022

Website

ZIMV Performance


Latest Earnings Call Transcripts


Q2 22Aug 11, 22 | 1:35 AM
Q1 22May 08, 22 | 3:00 AM

Peer Comparison


TickerCompany
KIDSOrthoPediatrics Corp.
ORGOOrganogenesis Holdings Inc.
AVNSAvanos Medical, Inc.
PACBPacific Biosciences of California, Inc.
OFIXOrthofix Medical Inc.
SIBNSI-BONE, Inc.
VREXVarex Imaging Corporation
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks